期刊文献+

脉络膜炎的吲哚青绿血管造影分析 被引量:5

Indocyanine green angiography findings in choroiditis
原文传递
导出
摘要 目的探讨脉络膜炎在吲哚青绿血管造影(indocyaninegreenangiography,ICGA)下的表现特征。方法对13例(16眼)脉络膜炎患者均作了ICGA和眼底荧光血管造影(fundusfluoresceinangiog-raphy,FFA)检查。结果ICGA可显示临床和FFA所发现不了的脉络膜炎性损害灶,其表现为:①脉络膜血管扩张,扩张的血管呈节段样外观、边缘粗糙;②脉络膜血管通透性增高所致的斑片状强荧光;③脉络膜充盈缺损;④脉络膜炎性水肿所致的异常暗背景荧光;⑤涡静脉扩张。结论ICGA不仅能较好的评价脉络膜炎的血液循环受损程度。 Purpose To study choroidal vascular abnormal characteristics in choroiditis using indocyanine green angiography(ICGA). Methods Thirteen cases(16 eyes)of choroiditis were examined with fundus fluorescein angiography(FFA) and ICGA. Results ICGA findings in choroiditis were as follows:(1)dilatation of choroidal vessels with segmentary appearance and irregular margins;(2)hyperpermeability of choroidal vessels;(3)choroidal filling defects;(4)choroidal hypofluorescence with edema;(5)dilatation of vortex veins. Conclusion ICGA is useful in evaluating the lesions and circulation disturbance of choroiditis which cannot usually be demonstrable in FFA.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 1998年第2期92-94,共3页 Chinese Journal of Ocular Fundus Diseases
关键词 荧光素 血管造影术 吲哚青绿 诊断 脉络膜炎 Fluorescein angiography Indocyanine green/diagnostic use Choroiditis/diagnosis
  • 相关文献

参考文献4

  • 1Bischoff PM,Flower RW. Ten years' experience with choroidal angiography using indoicyanine green dye:A new routine examination or an epilogue? Doc Ophthalmol,1985,60:235-291.
  • 2Iida T,Muraoka K,Tanaka Y,et al. Characteristics of choroidal fluorescence in infrared fundus angiography. Jpn J Clin Ophthalmol,1994,48:85-92.
  • 3Herbort CP, Borro.at TX, de-Courten C ,et al. Indocyanine green angiography in posterior uveitis. Klin Monatsbl Angenheilkd, 1996,208:321-326.
  • 4Yang CS,Lin CL,Lee FL,et al. Digital indocyanine green angiography in chorioretinal diseases. Chung-Hua-l-Hsueh-Tsa-Chih Taipei,1995,56:411-416.

同被引文献41

  • 1郑瑜,沙翔垠,黄娟.Vogt-小柳原田病的临床分析[J].实用医学杂志,2006,22(16):1893-1894. 被引量:5
  • 2SynderDA,TesslerHA.Vogt-Koyanagi-HaradaSyndromeOphthalmol,1980,90:69-75.
  • 3Ghosh P,Siea A,Cipppitelli M,et al.Activation of nuclear factor of activated T cells in a cyclosporine A-resistant Pathway[J].Biol Chem,1996,271:7700-7704.
  • 4张凤,中华眼底病杂志,1998年,14卷,2期,84页
  • 5Sugiura S.Vogt-Koyanagi-Harada disease.Jpn J Ophthalmol,1978,22:9-35
  • 6Hu SM M,et al.Advances in Ocular Immunology.Amsterdam:El-sevier 1994 335-338
  • 7Hu TS,Liu Q,zhang MF.Association with HLA-DRB1 * 0405、 DQA1 *0301、-DQB1 * 0401 in patients with Vogt-Koyanagi-Harada syndrome.Invest Ophthalmol Vis.Sci,1999,40(suppl):S864
  • 8Rubsamen PE,Gass JD.Vogt-Koyanagi-Harada syndrome:clinical course,therapy,and long-term visual outcome.Arch Ophthalmol,1991,109:682-687
  • 9Moorthy RS,Inomata H,Rao NA.Vogt-Koyanagi-Harada syndrome.Surv Ophthalmol,1995,39:265-292
  • 10Beniz J,Forster DJ,Lean JS,et al.Variations in clinical features of the Vogt-Koyanagi-Harada syndrome.Retina,1991,11:275-280

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部